Clinical Trial Recruitment and Site Selection Platform
The Meplis clinical trial recruitment and site selection platform helps teams identify the right sites faster and bring structure to study start-up.
Support site selection, feasibility, and activation within a structured environment designed for clinical trial recruitment and site matching, operating within a shared network of healthcare professionals and institutions.
Discuss Your Clinical Trial Use Case
WHO THIS IS FOR
Designed for Clinical Operations and Study Start-Up Teams
- Head of Clinical Operations
- Study Start-Up Managers
- Clinical Program Directors
- Compliance and Legal Leads
THE CHALLENGE
Why Clinical Trial Recruitment and Site Selection Remain Challenging
Clinical trial recruitment and site selection are still among the most operationally complex parts of clinical development.
Feasibility collection, site identification, investigator engagement, contracting, activation, and early recruitment monitoring are often managed across disconnected systems and stakeholders.
This can lead to:
- slow site selection and activation
- inconsistent feasibility data
- delays in contracting workflows
- limited visibility into site readiness
THE SOLUTION
A Structured Approach to Clinical Trial Recruitment and Site Selection
The Meplis Clinical Trial Recruitment & Site Matching Hub provides a structured environment for study start-up, feasibility, site selection, activation, and early recruitment coordination.
Clinical Trial Recruitment and Site Selection Platform for Pharma and Medtech
It operates within a shared network of healthcare professionals and research institutions, enabling more direct and consistent engagement with investigators, sites, and hospital-side research structures across studies.
HOW IT WORKS
Clinical Trial Recruitment and Site Selection Platform in Practice
The workspace follows the operational sequence of study start-up, where each step builds on the previous one:
- Create a study workspace
- Upload protocol and define study requirements
- Identify and invite potential sites and investigators
- Collect structured feasibility responses
- Review site fit and readiness
- Coordinate contracting and activation steps
- Monitor early recruitment progress and risks
WHAT YOU CAN DO
Clinical Trial Recruitment and Site Selection Platform Capabilities
Support site selection, feasibility, and activation in one structured workflow
- Identify potential sites and investigators
- Collect structured feasibility data
- Support site readiness and activation tracking
- Coordinate contracting workflows
- Monitor early recruitment progress
- Maintain visibility across study start-up activities
WHY THIS APPROACH IS DIFFERENT
Built for Structured Clinical Trial Workflows
Most tools used in clinical operations focus on individual steps such as feasibility or investigator management.
This approach is structured around the full operational workflow of study start-up — from protocol and feasibility through site selection, contracting, activation, and recruitment monitoring.
It also reflects the operational reality that both the investigator and the institution matter. In this model, the site is treated as a primary operational object, including infrastructure, readiness, and institutional workflows.
WHAT YOU CAN DO
Addressing the Structural Gaps in Trial Start-up
Clinical trial start-up is often slowed down by structural inefficiencies rather than isolated issues.
Feasibility data is inconsistent, site selection lacks context, contracting introduces delays, and recruitment risks are identified too late.
This approach focuses on structuring these steps into a connected workflow:
- standardizing feasibility data collection and reuse
- improving visibility into site readiness and context
- supporting earlier identification of recruitment risks
- reducing fragmentation between sponsors, investigators, and institutions
This shifts trial start-up from a series of disconnected tasks to a coordinated operational process.
EXPECTED OUTCOMES
What This Enables
- more structured site selection processes
- improved visibility into feasibility and site readiness
- reduced manual coordination during study start-up
- earlier identification of potential recruitment risks
- better continuity between study planning and execution
INTELLIGENCE LAYER
Contributes to a Company-Specific Lifecycle Intelligence Layer
This solution contributes to a broader system when used alongside other Meplis solutions.
When multiple solutions are activated, activities from clinical trial recruitment and site selection contribute to a company-specific Intelligence Layer — connecting insights across R&D, clinical trials, and post-market phases.
Over time, this supports a more complete and connected view of investigators, sites, readiness, participation, and performance across the lifecycle.
FROM STUDY START-UP TO LIFECYCLE CONTINUITY
Connected to the Wider Clinical Development Process
The Clinical Trial Recruitment & Site Matching Hub connects operationally with earlier and later processes.
This includes links to early-stage collaboration and protocol development, as well as downstream evidence and post-market activities, where continuity of sites, contributors, and institutional knowledge becomes important.
INTEGRATION
Works with Your Existing Clinical Systems
The hub is designed to complement existing sponsor and study infrastructure.
It can operate alongside study systems, contracting tools, and hospital-side environments, without requiring full system replacement.
START SMALL
Start with a Single Study
Organizations can begin with:
- one protocol
- a focused set of sites
- a defined feasibility and activation initiative
This allows teams to evaluate the approach within a contained study start-up scope before expanding further.
Bring More Structure to Clinical Trial Recruitment and Site Selection
Support study start-up with better visibility across site selection, feasibility, activation, and early recruitment.
Discuss Your Use Case
Frequently Asked Questions
A: It is a structured environment for managing study start-up activities, including protocol handling, site selection, feasibility, activation, and early recruitment coordination.
A:
Traditional tools often focus on static feasibility data or investigator lists.
This approach is structured around the full study start-up workflow, including feasibility, site readiness, contracting, activation, and early recruitment coordination.
A: No. The hub is designed to complement existing clinical and operational systems and can be used alongside current infrastructure.
A: No. Organizations can start with a single study and expand based on operational needs.
A: No. This solution reflects both the investigator and the institution, including site readiness, infrastructure, and activation requirements.
A: When used alongside other solutions, activities contribute to a company-specific Intelligence Layer that connects insights across the clinical development lifecycle.